Sign InBreakout Stocks of Week 24 @ HKEX
NASDAQ was down last week (week 23) by -4.70% ending at 25,709.43 points after falling -1,266.92 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Shanghai Pharmaceuticals Holding Co., Ltd. HKEX:2607. This stock has had a buy signal since May 29, 2026 when the price was HK$11.35 and is so far up 1.76% to HK$11.55. Some other companies are on our watchlist to, among these are Ping An of China CSI HK Dividend ETF HKEX:3070 Swire Pacific Limited HKEX:0019 Cheerwin Group Limited HKEX:6601 and Shanghai Microport Medbot (group) Co., Ltd. HKEX:2252 which all got a breakout pattern emerging.
| Date | Company | Price | Change |
|---|---|---|---|
| Shanghai Pharmaceuticals Holding Co., Ltd. | HK$11.55 | HK$11.66 ( 8th Jun 2026 ) | 0.95% |
| Ping An Of China Csi Hk Dividend Etf | HK$41.66 | HK$41.96 ( 8th Jun 2026 ) | 0.720% |
| Swire Pacific Limited | HK$83.30 | HK$83.45 ( 8th Jun 2026 ) | 0.180% |
| Cheerwin Group Limited | HK$2.26 | HK$2.25 ( 8th Jun 2026 ) | -0.442% |
| Shanghai Microport Medbot (group) Co., Ltd. | HK$25.10 | HK$24.56 ( 8th Jun 2026 ) | -2.15% |
The Shanghai Pharmaceuticals Holding Co., stock price gained 0.785% on the last trading day (Friday, 5th Jun 2026), rising from HK$11.46 to HK$11.55. During the last trading day the stock fluctuated 1.83% from a day low at HK$11.46 to a day high of HK$11.67. The price has been going up and down for this period, and there has been a -1.03% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 13 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately HK$31.07 million.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Shanghai Pharmaceuticals Holding Co., stock to perform well in the short-term.
About Shanghai Pharmaceuticals Holding Co., Ltd.:
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
The Ping An of China CSI HK Dividend ETF stock price gained 0.434% on the last trading day (Friday, 5th Jun 2026), rising from HK$41.48 to HK$41.66. During the last trading day the stock fluctuated 0.87% from a day low at HK$41.40 to a day high of HK$41.76. The price has been going up and down for this period, and there has been a -0.67% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 128 thousand more shares were traded than the day before. In total, 186 thousand shares were bought and sold for approximately HK$7.77 million.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Ping An of China CSI HK Dividend ETF stock to perform well in the short-term.
The Swire Pacific Limited stock price fell by -1.77% on the last day (Friday, 5th Jun 2026) from HK$84.80 to HK$83.30. During the last trading day the stock fluctuated 3.82% from a day low at HK$82.50 to a day high of HK$85.65. The price has fallen in 6 of the last 10 days and is down by -2.29% for this period. Volume has increased on the last day by 252 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 939 thousand shares were bought and sold for approximately HK$78.25 million.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Swire Pacific Limited:
Swire Pacific Limited engages in property, aviation, beverages, marine, and trading and industrial businesses in Hong Kong, Mainland China, rest of Asia, the United States, and internationally. The company's Property division develops, owns, and operates mixed-use properties. This division's property investment portfolio comprises office and retail premises, serviced apartments, other luxury residential accommodations, and commercial mixed-use developments; and trading portfolio consists of residential properties. It also owns and manages two hotels in Hong Kong and four hotels in Mainland China, as well as owns interests in the Mandarin Oriental hotel in the United States. The company's Aviation division provides flight catering and ramp, passenger and cargo services, and aircraft maintenance and modification services. As of December 31, 2021, it had a fleet of 234 aircraft. Its Beverages division owns rights to manufacture, market, and distribute refreshing soft drinks to consumers. The company's Trading & Industrial division retails and distributes footwear, apparel, and accessories through its 164 retail outlets; sells passenger cars, commercial vehicles, motorcycles, and scooters; operates a chain of 538 bakery stores; packages and sells sugar products under the Taikoo Sugar brand; and offers waste management services. The company was founded in 1816 and is based in Central, Hong Kong.
The Cheerwin Group Limited stock price fell by -0.88% on the last day (Friday, 5th Jun 2026) from HK$2.28 to HK$2.26. During the last trading day the stock fluctuated 2.24% from a day low at HK$2.23 to a day high of HK$2.28. The price has risen in 5 of the last 10 days but is still down by -3.42% for this period. Volume has increased on the last day by 404 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 922 thousand shares were bought and sold for approximately HK$2.08 million.
Cheerwin Group Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
The Shanghai Microport Medbot (group) Co., stock price gained 2.78% on the last trading day (Friday, 5th Jun 2026), rising from HK$24.42 to HK$25.10. During the last trading day the stock fluctuated 6.55% from a day low at HK$24.12 to a day high of HK$25.70. The price has been going up and down for this period, and there has been a -4.49% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 7 million shares were bought and sold for approximately HK$166.32 million.
Shanghai Microport Medbot (group) Co., holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
GOLDEN STAR
| Ticker | Change | Signal Date |
|---|---|---|
TPR
$140.47
|
0.306% | Jun 04 |
|
N
NVRI
$19.53
|
1.79% | May 20 |
RUN
$12.83
|
4.91% | May 06 |
GLBE
$31.61
|
1.71% | May 05 |
SAP
$172.39
|
5.53% | May 05 |
